Prothena Corporation plc ( PRTA) - Key Metrics
PRTA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0 | -$0.40 | ? | ? |
| 2025Q3 | $0.04 | -$0.68 | -$0.75 | -$0.75 |
| 2025Q2 | $0.08 | -$2.34 | -$0.86 | -$0.86 |
| 2025Q1 | $0.05 | -$1.12 | -$0.99 | -$0.99 |
PRTA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -5.95 |
| 2025Q3 | ? | -3.59 |
| 2025Q2 | ? | -0.65 |
| 2025Q1 | ? | -2.77 |
PRTA Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 5.53% | ? |
| 2025Q4 | -4.53% | ? |
| 2025Q3 | -7.72% | ? |
| 2025Q2 | -14.21% | ? |
| 2025Q1 | -8.01% | ? |
PRTA
Price: $9.25
52 week price:
Earnings Per Share: -2.81 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Ireland
Volume: 314000
Ebitda: -47.3 millionMarket Capitalization: 484.3 million